Key points are not available for this paper at this time.
Regionalized immune surveillance relies on the concerted efforts of diverse memory T cell populations. Of these, tissue-resident memory T (TRM) cells are strategically positioned in barrier tissues, where they enable efficient frontline defense against infections and cancer. However, the long-term persistence of these cells has been implicated in a variety of immune-mediated pathologies. Consequently, modulating TRM cell populations represents an attractive strategy for novel vaccination and therapeutic interventions against tissue-based diseases. Here, we provide an updated overview of TRM cell heterogeneity and function across tissues and disease states. We discuss mechanisms of TRM cell–mediated immune protection and their potential contributions to autoimmune disorders. Finally, we examine how TRM cell responses might be durably boosted or dampened for therapeutic gain.
Building similarity graph...
Analyzing shared references across papers
Loading...
Susan N. Christo
Simone L. Park
Scott N. Mueller
Annual Review of Immunology
University of Pennsylvania
The University of Melbourne
Translational Therapeutics (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Christo et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e62ad5b6db6435875bdc6d — DOI: https://doi.org/10.1146/annurev-immunol-101320-020220
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: